BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Said ZNA. An overview of occult hepatitis B virus infection. World J Gastroenterol 2011; 17(15): 1927-1938 [PMID: 21528070 DOI: 10.3748/wjg.v17.i15.1927] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 84] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Al-Sadeq DW, Taleb SA, Zaied RE, Fahad SM, Smatti MK, Rizeq BR, Al Thani AA, Yassine HM, Nasrallah GK. Hepatitis B Virus Molecular Epidemiology, Host-Virus Interaction, Coinfection, and Laboratory Diagnosis in the MENA Region: An Update. Pathogens 2019;8:E63. [PMID: 31083509 DOI: 10.3390/pathogens8020063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
2 Wang H, Li Y, Zhang C, Han Y, Zhang X, Zhu T, Li T. Immunological and virological responses to combined antiretroviral therapy in HIV/hepatitis B virus-coinfected patients from a multicenter cohort. AIDS 2012;26:1755-63. [DOI: 10.1097/qad.0b013e328355ced2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
3 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for management of chronic hepatitis B. Clin Mol Hepatol 2019;25:93-159. [PMID: 31185710 DOI: 10.3350/cmh.2019.1002] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 32.0] [Reference Citation Analysis]
4 El-Sayed MH, Said ZNA, Abo-Elmagd EK, Ebeid FSE, Salama II. High Risk of HBV Infection Among Vaccinated Polytransfused Children With Malignancy. J Pediatr Hematol Oncol 2021;43:e45-50. [PMID: 32769568 DOI: 10.1097/MPH.0000000000001887] [Reference Citation Analysis]
5 Zuure F, Bil J, Visser M, Snijder M, Boyd A, Blom P, Sonder G, Schinkel J, Prins M. Hepatitis B and C screening needs among different ethnic groups: A population-based study in Amsterdam, the Netherlands. JHEP Rep 2019;1:71-80. [PMID: 32039354 DOI: 10.1016/j.jhepr.2019.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Domingo E, Sheldon J, Perales C. Viral quasispecies evolution. Microbiol Mol Biol Rev. 2012;76:159-216. [PMID: 22688811 DOI: 10.1128/mmbr.05023-11] [Cited by in Crossref: 646] [Cited by in F6Publishing: 366] [Article Influence: 71.8] [Reference Citation Analysis]
7 Motaparthi K, Stanisic V, Van Voorhees AS, Lebwohl MG, Hsu S. From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis. J Am Acad Dermatol. 2014;70:178-186. [PMID: 24220724 DOI: 10.1016/j.jaad.2013.08.049] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
8 Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Makhema J, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S. In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm. Genes (Basel) 2018;9:E420. [PMID: 30134551 DOI: 10.3390/genes9090420] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
9 Esposito A, Sabia C, Iannone C, Nicoletti GF, Sommese L, Napoli C. Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing. Transfus Med Hemother 2017;44:263-72. [PMID: 28924431 DOI: 10.1159/000460301] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
10 Biswas A, Panigrahi R, Chandra PK, Banerjee A, Datta S, Pal M, Chakraborty S, Bhattacharya P, Chakrabarti S, Chakravarty R. Characterization of the occult hepatitis B virus variants circulating among the blood donors from eastern India. ScientificWorldJournal 2013;2013:212704. [PMID: 24302857 DOI: 10.1155/2013/212704] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
11 Fielding CM, Angulo P. Right upper-quadrant pain in a patient with drug abuse, secondary syphilis and occult hepatitis B virus. Med Princ Pract 2014;23:471-4. [PMID: 24662615 DOI: 10.1159/000360401] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
12 Sowole L, Labbett W, Patel M, O’Riordan A, Cross J, Davenport A, Haque T. The prevalence of occult hepatitis B virus (HBV) infection in a large multi-ethnic haemodialysis cohort. BMC Nephrol. 2015;16:12. [PMID: 25884422 DOI: 10.1186/s12882-015-0010-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
13 Patel NH, Joshi SS, Lau KCK, Castillo E, Coffin CS. Analysis of serum hepatitis B virus RNA levels in a multiethnic cohort of pregnant chronic hepatitis B carriers. J Clin Virol 2019;111:42-7. [PMID: 30639847 DOI: 10.1016/j.jcv.2019.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Kang X, Bai L, Han C, Qi X. Clinical Analysis and Prognostic Significance of Hepatitis B Virus Infections with Diffuse Large B-Cell Lymphoma. Cancer Manag Res 2020;12:2839-51. [PMID: 32425598 DOI: 10.2147/CMAR.S244381] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Sagnelli C, Macera M, Pisaturo M, Zampino R, Coppola M, Sagnelli E. Occult HBV infection in the oncohematological setting. Infection. 2016;44:575-582. [PMID: 27076347 DOI: 10.1007/s15010-016-0891-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
16 Ramezani A, Aghasadeghi MR, Ahmadi F, Razeghi E, Eslamifar A, Banifazl M, Sofian M, Bahramali G, Hekmat S, Aghakhani A. Isolated anti-hbc and occult HBV infection in dialysis patients. Nephrourol Mon. 2015;7:e22674. [PMID: 25738121 DOI: 10.5812/numonthly.22674] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
17 Song SH, Hwang SG. [Occult hepatitis B virus infection: transmission and reactivation]. Korean J Gastroenterol 2013;62:148-53. [PMID: 24077624 DOI: 10.4166/kjg.2013.62.3.148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
18 Ross RS, Stambouli O, Grüner N, Marcus U, Cai W, Zhang W, Zimmermann R, Roggendorf M. Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots--performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification. Virol J. 2013;10:72. [PMID: 23497102 DOI: 10.1016/j.antiviral.2011.12.011] [Cited by in Crossref: 92] [Cited by in F6Publishing: 80] [Article Influence: 11.5] [Reference Citation Analysis]
19 Blanco S, Balangero MC, Valle MC, Montini OL, Carrizo LH, Gallego SV. Usefulness of nucleic acid testing to reduce risk of hepatitis B virus transfusion-transmitted infection in Argentina: high rate of recent infections. Transfusion 2017;57:816-22. [PMID: 27917495 DOI: 10.1111/trf.13946] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
20 Balmasova IP, Yushchuk ND, Mynbaev OA, Alla NR, Malova ES, Shi Z, Gao CL. Immunopathogenesis of chronic hepatitis B. World J Gastroenterol 2014; 20(39): 14156-14171 [PMID: 25339804 DOI: 10.3748/wjg.v20.i39.14156] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
21 van Santen DK, Boyd A, Bruisten S, Sonder GJ, Prins M, van Houdt R. Frequent delayed spontaneous seroclearance of hepatitis B virus after incident HBV infection among adult high-risk groups. J Viral Hepat 2020;27:81-7. [PMID: 31520430 DOI: 10.1111/jvh.13205] [Reference Citation Analysis]
22 Chakravarty R. Role of molecular diagnostics in the management of viral hepatitis B. Expert Opin Med Diagn 2012;6:395-406. [PMID: 23480805 DOI: 10.1517/17530059.2012.690391] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Piauiense JNF, Costa CCS, Silva RJS, Cardoso YMN, Di Miceli JFF, Resque RL, Lemos JAR, Fischer B, Pinho JRR, Kupek E, Martins LC, Oliveira-Filho AB. Hepatitis B Virus Infection among People Who Use Illicit Drugs: Prevalence, Genotypes and Risk Factors in the State of Amapá, Northern Brazil. Subst Use Misuse 2020;55:1633-9. [PMID: 32338560 DOI: 10.1080/10826084.2020.1756334] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Aghasadeghi MR, Velayati AA, Mamishi S, Nabavi M, Aghakhani A, Bidari-Zerehpoosh F, Haghi Ashtiani MT, Sabeti S, Banifazl M, Azimian-Zavareh F, Motevalli F, Soleymani S, Ramezani A. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran. Arch Virol 2016;161:3405-11. [PMID: 27613286 DOI: 10.1007/s00705-016-3050-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
25 Diarra B, Yonli AT, Sorgho PA, Compaore TR, Ouattara AK, Zongo WA, Tao I, Traore L, Soubeiga ST, Djigma FW. Occult Hepatitis B Virus Infection and Associated Genotypes among HBsAg-negative Subjects in Burkina Faso. Mediterr J Hematol Infect Dis. 2018;10:e2018007. [PMID: 29326804 DOI: 10.4084/mjhid.2018.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
26 Abd El Kader Mahmoud O, Abd El Rahim Ghazal A, El Sayed Metwally D, Elnour AM, Yousif GE. Detection of occult hepatitis B virus infection among blood donors in Sudan. J Egypt Public Health Assoc 2013;88:14-8. [PMID: 23528527 DOI: 10.1097/01.EPX.0000427065.73965.c8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
27 Elkady A, Aboulfotuh S, Ali EM, Sayed D, Abdel-Aziz NM, Ali AM, Murakami S, Iijima S, Tanaka Y. Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt. World J Gastroenterol 2013; 19(37): 6214-6220 [PMID: 24115819 DOI: 10.3748/wjg.v19.i37.6214] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
28 Madhavan A, Sachu A, Balakrishnan AK, Balakrishnan S, Vasudevapanicker J. Prevalence of Anti-HBc Antibodies among HBsAg Negative Individuals and Its Association with Occult Hepatitis B. J Lab Physicians 2021;13:1-5. [PMID: 34054234 DOI: 10.1055/s-0041-1723046] [Reference Citation Analysis]
29 Nagakawa O, Miyatomi Y, Shigeta Y, Inayama E, Murakami K, Sakai T, Kouno T, Masai M, Shirai K, Yoshida T. Occult Hepatitis B Virus Infection in Japanese Chronic Hemodialysis Patients: Occult HBV in Japanese HD Patients. Therapeutic Apheresis and Dialysis 2013;17:289-92. [DOI: 10.1111/1744-9987.12006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
30 Cardona NE, Loureiro CL, Garzaro DJ, Duarte MC, García DM, Pacheco MC, Chemin I, Pujol FH. Unusual presentation of hepatitis B serological markers in an Amerindian community of Venezuela with a majority of occult cases. Virol J. 2011;8:527. [PMID: 22152023 DOI: 10.1186/1743-422x-8-527] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
31 Matos MA, Ferreira RC, Rodrigues FP, Marinho TA, Lopes CL, Novais AC, Motta-Castro AR, Teles SA, Souto FJ, Martins RM. Occult hepatitis B virus infection among injecting drug users in the Central-West Region of Brazil. Mem Inst Oswaldo Cruz 2013;108:S0074-02762013000300386. [PMID: 23778654 DOI: 10.1590/S0074-02762013000300019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
32 Faustini Pereira JL, Galant LH, Rossi D, Telles da Rosa LH, Garcia E, de Mello Brandão AB, Marroni CA. Functional Capacity, Respiratory Muscle Strength, and Oxygen Consumption Predict Mortality in Patients with Cirrhosis. Can J Gastroenterol Hepatol 2016;2016:6940374. [PMID: 27559536 DOI: 10.1155/2016/6940374] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
33 Said ZN, Sayed MHE, Salama II, Aboel-Magd EK, Mahmoud MH, Setouhy ME, Mouftah F, Azzab MB, Goubran H, Bassili A, Esmat GE. Occult hepatitis B virus infection among Egyptian blood donors. World J Hepatol 2013; 5(2): 64-73 [PMID: 23646231 DOI: 10.4254/wjh.v5.i2.64] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
34 Batsis ID, Wasuwanich P, Karnsakul WW. The management of hepatitis B and hepatitis C in children. Minerva Pediatr 2019;71:59-75. [PMID: 30334626 DOI: 10.23736/S0026-4946.18.05410-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Mahmoud OAEK, Ghazal AAER, Metwally DES, Shamseya MM, Hamdallah HM. Detection of occult hepatitis B virus among chronic hepatitis C patients. Alexandria Journal of Medicine 2016;52:115-23. [DOI: 10.1016/j.ajme.2015.06.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Hockenbery DM, Strasser SI, Mcdonald GB. Gastrointestinal and Hepatic Complications. In: Forman SJ, Negrin RS, Antin JH, Appelbaum FR, editors. Thomas’ Hematopoietic Cell Transplantation. Chichester: John Wiley & Sons, Ltd; 2015. pp. 1140-60. [DOI: 10.1002/9781118416426.ch94] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
37 Karimi G, Zadsar M, Vafaei N, Sharifi Z, FalahTafti M. Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors. Virol J 2016;13:36. [PMID: 26944046 DOI: 10.1186/s12985-016-0492-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
38 Liu C, Chang L, Ji H, Guo F, Zhang K, Lin G, Zhang R, Li J, Wang L. Prevalence of HBV DNA among 20 million seronegative blood donations in China from 2010 to 2015. Sci Rep. 2016;6:36464. [PMID: 27833112 DOI: 10.1038/srep36464] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
39 Samiee S, Kanavi MR, Javadi MA, Bagheri A, Balagholi S, Hashemi MS. Real Time Polymerase Chain Reaction for Hepatitis B Screening in Donor Corneas in the Central Eye Bank of Iran. J Ophthalmic Vis Res 2018;13:392-6. [PMID: 30479707 DOI: 10.4103/jovr.jovr_157_17] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Korean Association for the Study of the Liver. KASL clinical practice guidelines: management of chronic hepatitis B. Clin Mol Hepatol 2016;22:18-75. [PMID: 27044762 DOI: 10.3350/cmh.2016.22.1.18] [Cited by in Crossref: 115] [Cited by in F6Publishing: 126] [Article Influence: 23.0] [Reference Citation Analysis]
41 Hsu CW, Liang KH, Lin CL, Wang TH, Yeh CT. Platelet counts modulate the quantitative relationship between hepatitis B viral DNA and surface antigen concentrations: a cross-sectional study of hematological, histological and viral factors. BMC Infect Dis 2017;17:9. [PMID: 28056849 DOI: 10.1186/s12879-016-2121-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Vassilopoulos D, Calabrese LH. Viral hepatitis: review of arthritic complications and therapy for arthritis in the presence of active HBV/HCV. Curr Rheumatol Rep. 2013;15:319. [PMID: 23436024 DOI: 10.1007/s11926-013-0319-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
43 Huang X, Hollinger FB. Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review. J Viral Hepat. 2014;21:153-162. [PMID: 24438677 DOI: 10.1111/jvh.12222] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 6.9] [Reference Citation Analysis]
44 Powell EA, Boyce CL, Gededzha MP, Selabe SG, Mphahlele MJ, Blackard JT. Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans. J Gen Virol 2016;97:1615-24. [PMID: 27031988 DOI: 10.1099/jgv.0.000469] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
45 Ozoya OO, Chavez J, Sokol L, Dalia S. Optimizing antiviral agents for hepatitis B management in malignant lymphomas. Ann Transl Med 2017;5:39. [PMID: 28251118 DOI: 10.21037/atm.2016.12.25] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
46 Al-Kassar A, Al-Shdaifat A. Iatrogenic occult infection causing hypoglycemia in a teenage female. Ann Saudi Med 2019;39:359-61. [PMID: 31580708 DOI: 10.5144/0256-4947.2019.359] [Reference Citation Analysis]
47 Kang JW, Seo JH, Youn KW, Seo YI, Huh K, Choi GR, Min HK, Oh DJ, Jo HJ, Kim JN. Use of supplemental anti-HBc testing of donors showing non-discriminating reactive results in multiplex nucleic acid testing. Vox Sang 2017;112:622-7. [PMID: 28891069 DOI: 10.1111/vox.12553] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
48 Chen X, Zhou Q, Dong S, Wang S, Liu R, Wu X, Li S. Multiple Cross Displacement Amplification Linked with Nanoparticles-Based Lateral Flow Biosensor in Screening of Hepatitis B Virus in Clinical Application. Infect Drug Resist 2021;14:1219-29. [PMID: 33790592 DOI: 10.2147/IDR.S297645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Morales-Romero J, Vargas G, García-Román R. Occult HBV infection: a faceless enemy in liver cancer development. Viruses. 2014;6:1590-1611. [PMID: 24717680 DOI: 10.3390/v6041590] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
50 Agyeman AA, Ofori-Asenso R. Prevalence of HIV and hepatitis B coinfection in Ghana: a systematic review and meta-analysis. AIDS Res Ther 2016;13:23. [PMID: 27190544 DOI: 10.1186/s12981-016-0107-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
51 Chen H, Su T, Tseng T, Yang W, Chen T, Chen P, Chen D, Kao J, Liu C. Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up. Journal of the Formosan Medical Association 2017;116:697-704. [DOI: 10.1016/j.jfma.2016.11.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
52 Ribeiro CRA, de Almeida NAA, Martinelli KG, Pires MA, Mello CEB, Barros JJ, de Paula VS. Cytokine profile during occult hepatitis B virus infection in chronic hepatitis C patients. Virol J 2021;18:15. [PMID: 33435966 DOI: 10.1186/s12985-021-01487-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Kishk R, Nemr N, Elkady A, Mandour M, Aboelmagd M, Ramsis N, Hassan M, Soliman N, Iijima S, Murakami S, Tanaka Y, Ragheb M. Hepatitis B surface gene variants isolated from blood donors with overt and occult HBV infection in north eastern Egypt. Virol J 2015;12:153. [PMID: 26420301 DOI: 10.1186/s12985-015-0389-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
54 Covolo L, Pollicino T, Raimondo G, Donato F. Occult hepatitis B virus and the risk for chronic liver disease: a meta-analysis. Dig Liver Dis. 2013;45:238-244. [PMID: 23146778 DOI: 10.1016/j.dld.2012.09.021] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
55 Bessone F. Re-appraisal of old and new diagnostic tools in the current management of chronic hepatitis B. Liver Int. 2014;34:991-1000. [PMID: 25098191 DOI: 10.1111/liv.12499] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
56 Afyon M, Artuk C. Is occult Hepatitis B virus infection with detectable anti-HBs infectious or not? Middle East J Dig Dis 2016;8:147-9. [PMID: 27252823 DOI: 10.15171/mejdd.2016.21] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
57 Tan WS, Ho KL. Phage display creates innovative applications to combat hepatitis B virus. World J Gastroenterol 2014; 20(33): 11650-11670 [PMID: 25206271 DOI: 10.3748/wjg.v20.i33.11650] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
58 Salehi-Vaziri M, Sadeghi F, Almasi Hashiani A, Gholami Fesharaki M, Alavian SM. Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis. Hepat Mon 2016;16:e35577. [PMID: 27257428 DOI: 10.5812/hepatmon.35577] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
59 Datta S, Khillan K, Ranjan V, Wattal C. Nucleic acid amplification test: Bridging the gap in blood safety & re-evaluation of blood screening for cryptic transfusion-transmitted infection among Indian donors. Indian J Med Res 2019;149:389-95. [PMID: 31249205 DOI: 10.4103/ijmr.IJMR_1340_17] [Reference Citation Analysis]
60 Korean Association for the Study of the Liver. KASL Clinical Practice Guidelines: Management of chronic hepatitis B. Clin Mol Hepatol. 2012;18:109-162. [PMID: 22893865 DOI: 10.3350/cmh.2012.18.2.109] [Cited by in Crossref: 109] [Cited by in F6Publishing: 121] [Article Influence: 12.1] [Reference Citation Analysis]
61 Luo Q, Zhong Y, Yang Y, Xiong Q, Hu Z, Lu W, Huang P, Zhang N. Clinical characteristics and chronicity of acute hepatitis B induced by lamivudine-resistant strains. J Med Virol 2012;84:1558-61. [DOI: 10.1002/jmv.23369] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
62 Aghakhani A, Mohraz M, Aghasadeghi MR, Banifazl M, Vahabpour R, Karami A, Foroughi M, Ramezani A. Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination. Int J STD AIDS 2016;27:967-72. [DOI: 10.1177/0956462415602419] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
63 Koga H, Kai K, Aishima S, Kawaguchi A, Yamaji K, Ide T, Ueda J, Noshiro H. Occult hepatitis B virus infection and surgical outcomes in non-B, non-C patients with curative resection for hepatocellular carcinoma. World J Hepatol 2017; 9(35): 1286-1295 [PMID: 29290910 DOI: 10.4254/wjh.v9.i35.1286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
64 Marinho TA, Lopes CLR, Teles SA, Matos MAD, Matos MADD, Kozlowski AG, Oliveira MPD, Silva ÁMDCE, Martins RMB. Epidemiology of hepatitis B virus infection among recyclable waste collectors in central Brazil. Rev Soc Bras Med Trop 2014;47:18-23. [DOI: 10.1590/0037-8682-0177-2013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
65 Kong D, Wu D, Wang T, Li T, Xu S, Chen F, Jin X, Lou G. Detection of viral antigens in renal tissue of glomerulonephritis patients without serological evidence of hepatitis B virus and hepatitis C virus infection. Int J Infect Dis. 2013;17:e535-e538. [PMID: 23474175 DOI: 10.1016/j.ijid.2013.01.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
66 Abrão J, Carvalho M, Garcia P, Contti M, Andrade L. Safety of Kidney Transplantation Using Anti-HBc–Positive Donors. Transplantation Proceedings 2014;46:3408-11. [DOI: 10.1016/j.transproceed.2014.06.067] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
67 Bal T, Onlen Y. The prevalence of occult hepatitis B in chronic hepatitis C patients treated with interferon-based antiviral therapy. Arab J Gastroenterol 2018;19:33-6. [PMID: 29503077 DOI: 10.1016/j.ajg.2018.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Wang H, Wang M, Huang J, Xu R, Liao Q, Shan Z, Zheng Y, Rong X, Tang X, Li T, Wang W, Li C, Fu Y. Novel hepatitis B virus surface antigen mutations associated with occult genotype B hepatitis B virus infection affect HBsAg detection. J Viral Hepat 2020;27:915-21. [PMID: 32336003 DOI: 10.1111/jvh.13309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Almeida RW, Mello FCDA, Menegoy IV, Santo MPDE, Ginuíno CF, Sousa PSF, Villar LM, Lampe E, Lewis-Ximenez LL. Detection and molecular characterisation of a diagnosis escape variant associated with occult hepatitis B virus in Brazil. Mem Inst Oswaldo Cruz 2017;112:485-91. [PMID: 28591309 DOI: 10.1590/0074-02760160477] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
70 Pisano MB, Blanco S, Carrizo H, Ré VE, Gallego S. Hepatitis B virus infection in blood donors in Argentina: prevalence of infection, genotype distribution and frequency of occult HBV infection. Arch Virol 2016;161:2813-7. [PMID: 27383207 DOI: 10.1007/s00705-016-2960-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
71 Ross RS, Stambouli O, Grüner N, Marcus U, Cai W, Zhang W, Zimmermann R, Roggendorf M. Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots--performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification. Virol J. 2013;10:72. [PMID: 23497102 DOI: 10.1186/1743-422x-10-72] [Cited by in Crossref: 53] [Cited by in F6Publishing: 29] [Article Influence: 6.6] [Reference Citation Analysis]
72 Azarkar Z, Ziaee M, Ebrahimzadeh A, Sharifzadeh G, Javanmard D. Epidemiology, risk factors, and molecular characterization of occult hepatitis B infection among anti-hepatitis B core antigen alone subjects. J Med Virol 2019;91:615-22. [PMID: 30345529 DOI: 10.1002/jmv.25343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Besharat S, Katoonizadeh A, Moradi A. Potential mutations associated with occult hepatitis B virus status. Hepat Mon. 2014;14:e15275. [PMID: 24829588 DOI: 10.5812/hepatmon.15275] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
74 Xiong QF, Zhong YD, Hu ZL, Yang YF. Successful treatment of occult hepatitis B virus infection related membranous nephropathy after entecavir therapy. Acta Clin Belg 2015;70:223-5. [PMID: 25510219 DOI: 10.1179/2295333714Y.0000000108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Sood AK, Pangotra C, Manrai M. Prevalence of occult hepatitis B infection in patients visiting tertiary care hospital. Med J Armed Forces India 2016;72:140-4. [PMID: 27257324 DOI: 10.1016/j.mjafi.2016.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
76 Mortensen E, Kamali A, Schirmer PL, Lucero-Obusan C, Winston CA, Oda G, Winters MA, Durfee J, Martinello RA, Davey VJ, Holodniy M. Are current screening protocols for chronic hepatitis B virus infection adequate? Diagn Microbiol Infect Dis 2016;85:159-67. [PMID: 27009896 DOI: 10.1016/j.diagmicrobio.2015.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
77 Portilho MM, Martins PP, Lampe E, Villar LM. A comparison of molecular methods for hepatitis B virus (HBV) DNA detection from oral fluid samples. J Med Microbiol. 2012;61:844-851. [PMID: 22403138 DOI: 10.1099/jmm.0.040238-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
78 Olotu AA, Oyelese AO, Salawu L, Audu RA, Okwuraiwe AP, Aboderin AO. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virol J 2016;13:76. [PMID: 27150469 DOI: 10.1186/s12985-016-0533-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
79 Wen X, Su H, Wang Y, Pu Z, Gao J, Ji Z, Yuan X, Li X, Zhang W, Zhang L, Long Y, Yan Y, Shao Z. Prevalence and natural course of occult hepatitis B virus infection in residents of 2 communities of Wuwei City, Gansu Province, China. J Viral Hepat 2018;25:281-8. [DOI: 10.1111/jvh.12805] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
80 Kang S, Kim M, Lee W. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc. Arch Virol 2014;159:227-33. [DOI: 10.1007/s00705-013-1810-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
81 Kwak MS, Kim YJ. Occult hepatitis B virus infection. World J Hepatol 2014; 6(12): 860-869 [PMID: 25544873 DOI: 10.4254/wjh.v6.i12.860] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 6.6] [Reference Citation Analysis]
82 Carimo AA, Gudo ES, Maueia C, Mabunda N, Chambal L, Vubil A, Flora A, Antunes F, Bhatt N. First report of occult hepatitis B infection among ART naïve HIV seropositive individuals in Maputo, Mozambique. PLoS One 2018;13:e0190775. [PMID: 29320552 DOI: 10.1371/journal.pone.0190775] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
83 Muselmani W, Habbal W, Monem F. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors. Transfus Med 2013;23:265-8. [PMID: 23621787 DOI: 10.1111/tme.12043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
84 Souza MT, Pinho TL, Santos MD, Santos Ad, Monteiro VL, Fonsêca LM, Ferreira PA, Ferreira Ade S. Prevalence of hepatitis B among pregnant women assisted at the public maternity hospitals of São Luís, Maranhão, Brazil. Braz J Infect Dis 2012;16:517-20. [PMID: 23168305 DOI: 10.1016/j.bjid.2012.07.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
85 Ansari N, Makvandi M, Samarbaf-Zadeh AR. Hepatitis B virus genotyping among patients with cirrhosis. Jundishapur J Microbiol. 2015;8:e14571. [PMID: 25964845 DOI: 10.5812/jjm.14571] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]